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ABSTRACT
Background: Increased homocysteine plasma levels are associated with increased thrombosis. Acute coronary syndromes (ACS) is the process of 
thrombosis in coronary arteries induced by atherosclerosis plaque ruptures, fissures or erosion. The purpose of this study is to analyze the relationship 
between increased levels of homocysteine in the blood and the area of ischemic injury in myocardium of patients with ACS. 
Methods : In the frame of Cardio Metabolic Investigation (Carmetin); a cross-sectional study was done among ACS patients (n = 40) admitted at Dr. 
Kariadi Hospital from August to November 2009. Serum homocysteine were obtained by Enzyme Linked Immuno Assay (ELISA) at the arrival. 
Myocardial injury area were assessed indirectly by levels of cardiac Troponin I (cTnI) at the time of arrival and 24 hours later. Homocysteine levels 
were divided into quintiles.
Results: There were twenty seven male patients (67.5%) and thirteen female patients (3.5%). Eighteen patients (45%) had a negative cTnI (defined as 
cTnI ≤ 0.10 ng/ml), while twenty two patients had positive  cTnI (55%) at arrival. At the peak levels, only one patients had a negative cTnI levels. 
There is significant relationship between homocysteine level and the peak of cTnI level (p=0.048). Homocysteine levels were significantly higher in 
cTnI positive than cTnI negative patients (p<0.01)
Conclusion: The increased of homocysteine plasma level is associated with increased of myocardial injury area in ACS patients.
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HUBUNGAN ANTARA KADAR HOMOSISTEIN DAN AREA LUAR INFARK MIOKARD
PADA PASIEN DENGAN SINDROM KORONER AKUT
ABSTRAK
Latar belakang: Kadar homosistein plasma yang meninggi berhubungan dengan peningkatan thrombosis. Sindrom koroner akut 
(ACS) merupakan proses trombosis dalam arteri-arteri koroner yang diinduksi oleh ruptur, fisura atau erosi plak atherosclerosis. 
Tujuan penelitian untuk menganalisis hubungan antara peninggian kadar homosistein darah dan area jejas iskemik pada miokardium 
pasien dengan ACS. 
Metode: Studi ini menggunakan konsep Cardio Metabolic Investigation (Carmetin); dilakukan studi cross-sectional pada pasien ACS 
(n=40) yang dirawat di RSUP Dr. Kariadi Semarang, sejak Agustus sampai November 2009. Kadar homosistein serum diperiksa 
menggunakan  teknik Enzyme Linked Immuno Assay (ELISA) di awal kedatangan pasien. Area jejas miokardial Dinilai secara tidak 
langsung memakai penilaian kadar Troponin I (cTnI) kardia di awal kedatangan dan 24 jam sesudahnya. Kadar homosistein dibagi 
menjadi beberapa quintiles.
Hasil: Sebanyak 27 pasien pria (67,5%) dan 13 wanita (32,5%). Sejumlah 18 pasien (45%) terdapat cTnI negatif (kadar cTnI ≤ 0,10 ng/ml), 
22 pasien cTnI positif (55%) di awal kedatangan. Saat kadar puncak, hanya didapatkan satu pasien dengan cTnI negatif. Terdapat 
hubungan yang signifikan antara kadar homosistein dan peningkatan kadar cTnI (p=0,048). Kadar homosistein lebih tinggi secara 
signifikan pada pasien dengan cTnI positif dibanding cTnI negatif (p<0,01).
Simpulan: Peninggian kadar homosistein plasma berhubungan dengan peningkatan area jejas myocardial pada pasien ACS.
Kata kunci: Homosistein plasma, jejas miokardial, acute coronary syndromes
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METHODS
Type and Research Design
This study is a part of Cardiometabolic 
Investigation (Carmetin), the design was cross-
sectional of consecutive patients (n=40), admitted at 
the Coronary Care Unit, Cardiac Center of Kariadi 
Hospital Semarang. Laboratory analysis was done at 
GAKY Laboratory of Kariadi Hospital Semarang. The 
study began from August to November 2009.
Measurement of injured myocardial area and 
homocysteine 
Homocysteine levels were taken from venous 
blood. Myocardial infarction area was measured 
indirectly using the levels of cardiac troponin I (cTnI) 
at admission and 24 hours later. Serum stored in -2°C 
temperatures before measured by the method of 
enzyme link immune assay (ELISA). 
Data Analysis
Univariate analysis performed to determine the 
proportion of descriptions, rates, and the standard 
deviation of each group. Value of troponin I is in the 
form of quantitative. The data is then divided into 5 
homocysteine quintile, the differences between the 
categories were tested by using Chi Square test. To test 
the normality of data, one sample Kolmogorov-
Smirnov was used. If there is a normal distribution, 
independent t-test was conducted for two variables 
and analysis of variance (ANOVA) for more than two 
variables, whereas if the data distribution is not normal 
non-parametric test Kruskal-Wallis is used. Data 
analysis was using SPSS for Windows.
RESULTS
The number of subjects in this study was 40 
patients. Most of the patients were male with age 
average of 56.3 years. Of 40 subjects of research, the 
mean homocysteine levels were in quintile 4. At the 
time of arrival 18 patients were diagnosed with UAP 
and Non-STEMI as differential diagnose (cTnI <0.1 
mcg/liter) while 22 patients were diagnosed with 
myocardial infarction (cTnI> 0.1 mcg / liter). Of 18 
patients with UAP on arrival, 17 patients experienced 
myocardial infarction by serial measurement of 
enzyme cTnI. Hypertension is the traditional risk 
factors that are most commonly found in this study, as 
much as 62.5% (Table 1).
INTRODUCTION
Epidemiological studies indicate that increased 
plasma homocysteine concentrations are associated 
with increased risk of atheromatous formation in the 
blood vessels and risk of thrombosis. Coronary artery 
disease includes either atheromatous lesion formation 
or thrombosis triggered by plaque rupture, process in 
1,2patients with acute coronary syndrome.
Previous study reported that elevated levels of 
plasma homocysteine play role as independent risk 
3factor of coronary artery disease.  Clear evidence was 
more prominent in patients with congenital disease of 
homocystinuria, where cysthationine enzyme β-
synthase or methylene tetrahydrofolate reductase 
were not expressed genetically for homocysteine 
metabolism. This situation causes increased plasma 
homocysteine levels and affect the occurrence of 
4atherosclerosis in most blood vessels in the early life.  
Nygard, O et al in his study proved that elevated levels 
of plasma homocysteine is a predictor of mortality in 
patients with proven CHD who underwent  
5catheterization.
Atheromatous lesions mechanism for increased 
plasma homocysteine is still unclear, but the elevated 
homocysteine plasma levels and an increased risk of 
thrombotic have been proven through in vitro and in 
vivo research, and a lot of researches were done to find 
the relationship between homocysteine with the 
factors involved in the coagulation cascade. 
Homocysteine inhibits expression of trombomodulin 
on endothelial cell surface, inhibits activation of 
protein C, induces tissue factor activity, promotes 
expression of clotting factors II, V, X, and XII, inhibits 
the binding of antitrombin III and endothelium, 
reducing the number of receptors on the endothelial 
tissue plasminogen activator, increasing the binding of 
lipoprotein (a) to fibrin, enhancing platelet 
aggregation. The combination of these disturbances 
6, 7, 8will result in increased thrombogenesis.
Acute coronary syndrome (ACS) consist of ST-
segment elevation Myocardial Infarction (STEMI), 
Non-ST Segment Elevation Myocardial Infarction 
(NSTEMI) and Unstable angina pectoris (UAP) is a 
process of thrombus formation in coronary arteries, 
which is triggered by atherosclerotic plaque rupture, 
erosion or fissure. The process of atherosclerotic 
plaque rupture exposing the tissue with blood flow, 
then the effect is followed by activation of the 
9coagulation cascade to form thrombus.
The aim of this study is to investigate the 
relationship between homocysteine levels and 
myocardial injury area of ACS patients.
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The relationship between homocysteine levels 
with cTnI levels was first done by dividing plasma 
homocysteine levels into quintiles. Figure 1 shows the 
relationship between the levels of early cTnI with 
homocysteine levels. There is a significant realtionship 
between the increasing of initial cTnI and 
homocysteine quintile. (0.15, 0.04, 0.22, 0.69 and 1.3 
µg/liter in each quintile homocysteine, Kruskal-
Wallis, p= 0.02).
The relationships between homocysteine 
concentrations with cTnI still visible on the cTnI peak 
levels. Figure 2 illustrates the significant relationship 
between the increase in average peak levels cTnI and 
homocysteine levels (0.43, 1.05, 0.74, 1.87, and 4.5 µg/ 
liter in each quintile homocysteine, Kruskal-Wallis, p= 
0.04)
There is significant difference in homocysteine 
concentration between admission cTnI negative and 
cTnI positive in all patients (9.6±2.1 vs 17.63±10.6 
µmol/liter, respectively, p<0.01). Significant 
Tabel 1. Basic characteristic of the study group
Variabel Studi
Age (years)
Male (% total)
All n = 40
56.33 ± 10.6
67.5 %
Hypertension (% total)
Diabetes mellitus (% total)
62.5 %
20 %
Current smoking (% total) 
Dyslipidemia (% total)
55 %
45 %
Homocysteine (µmol/liter)
Admission cTnI (µg/liter)
14.03 ± 8.89
0.7 ± 2.33
Admission cTnI > 0.1 µg/liter (% total) 55 %
Peak cTnI (µg/liter)
Peak cTnI > 0.01 µg/liter (% total)
2.76 ± 8.48
97.5 %
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Figure 1. Admission cTnI levels by quintiles of homocysteine
Figure 2. Peak cTnI Levels by quintiles of homocysteine
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Homocysteine levels can be lowered by folic acid 
supplementation, vitamin B12 and vitamin B6 or a 
combination of nutritional intervention consists of 
these three vitamins. Those vitamins act on 
homocysteine utilization has been reported have an 
effect on cardiovascular risk reduction. Homocysteine 
is a methylation reaction product which will be 
converted to methionine with methyltetrahydrofolate 
assistance, this conversion requires a coenzyme, while 
vitamin B6 is needed for other mechanisms of 
homocysteine utilization. Further research is needed to 
assess the therapeutic effect of homocysteine reduction 
on the area of myocardial infarction or intervention 
through these three vitamin diet (alone or 
14combination) or by supplementation.
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